8 results
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... Pneumonia (CAP) ... fluoroquinolone #IDSA ... #Pneumonia #Antibiotics ... Management #Guidelines #pharmacology
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Antimicrobial Treatment ... Parenteral #IV #Antibiotics ... #Osteomyelitis ... #pharmacology # ... idsa
Antibiotic treatment durations for first line antibiotics recommended by Public Health England (PHE) guidance
 • Acute
Antibiotic treatment ... • Community acquired ... pneumonia and CRB65 ... pneumonia and CRB65 ... #pharmacology #
Selected Oral Antibacterial Agents With Excellent Oral Bioavailability Commonly Used to Treat Patients With Native Vertebral
#Oral #Antibiotics ... #Osteomyelitis ... #management #treatment ... #pharmacology # ... idsa
Community Acquired Pneumonia (CAP) - Diagnosis and Management

Pneumonia Signs/Symptoms:
 • Confusion/disorientation (LR + 1.9)
 • Cough
Community Acquired ... 96.1% • Empiric antibiotic ... procalcitonin level Treatment ... #Pulmonary #Community ... #Acquired
IDSA - Approach to Treating a Patient With Diabetic Foot Osteomyelitis
When to consider a trial of
IDSA - Approach ... Diabetic Foot Osteomyelitis ... of nonsurgical treatment ... 48–72 h if on treatment ... not otherwise required
Macrolides - Erythromycin, Clarithromycin, Azithromycin - Antibiotics Class Overview

50S Ribosomal Inhibitor (PO and IV)
Spectrum: Atypical organisms
Azithromycin - Antibiotics ... exacerbations, community-acquired ... pneumonia, sinusitis ... Used for MAC treatment ... #Pharmacology #Antibiotics
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... (Such As Focal Pneumonia ... Infection (Diffuse Pulmonary ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology